ArticleFrontiers in cardiovascular medicine2025
Machine learning algorithms for predicting atrial fibrillation using single-lead data derived from 12-lead ECGs.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From wrist to heart: clinical validation and real-world translation of wearable and portable AI-enhanced electrocardiography.European heart journal. Digital health · 2026Review
- Top developments in clinical cardiac electrophysiology-2025.Heart rhythm O2 · 2026Review
- Device-Detected Atrial Fibrillation: Why Time-Based Thresholds Are No Longer Fit for Purpose.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Wearable electrocardiogram (ECG) monitoring devices that utilize single-lead ECG technology have become valuable tools for identifying paroxysmal atrial fibrillation (AF). This study aimed to develop a machine learning (ML) algorithm to predict new-onset AF by training it on single-lead data extracted from 12-lead ECG recordings. Methods and results: Patients who underwent 12-lead ECG between January 2010 and December 2021 were classified into two groups based on a review of their medical records and diagnostic codes: the AF group and the normal group. An ML model was created using single-lead ECG data, excluding three augmented leads, and incorporating 60 calculated statistical variables for each of the remaining single leads. The model's performance was assessed using several metrics, including the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, accuracy, and F1 score. We trained the ML model on 248,612 ECGs collected from 106,606 patients, of whom 11,810 had definite AF. Among the single-lead machine learning models developed from each of the nine individual leads, lead I demonstrated the best performance. The AUROC of the single-lead ECG ML model using lead I was 0.801, while the AUROC of the 12-lead ECG ML model was 0.816. Conclusion: The single-lead ECG ML model has shown promise in predicting new-onset atrial fibrillation (AF), particularly with lead I. Its performance is comparable to that of the 12-lead model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.